These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 13678484)

  • 21. A comparison of the antihypertensive effects of candesartan cilexetil and losartan in patients with mild to moderate hypertension.
    Andersson OK; Neldam S
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S63-4. PubMed ID: 9331011
    [No Abstract]   [Full Text] [Related]  

  • 22. [Changed guidelines of the German High Blood Pressure League. AT(1) blocker in the first league now].
    MMW Fortschr Med; 2002 Oct; 144(44):55. PubMed ID: 12494603
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-acting blood pressure reduction by candesartan cilexetil in patients with hypertension.
    Bönner G; Fuchs W
    Curr Med Res Opin; 2005 Jun; 21(6):935-40. PubMed ID: 15969893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Normalizing the expression of nitric oxide synthase by low-dose AT1 receptor antagonism parallels improved vascular morphology in hypertensive rats.
    Bennai F; Morsing P; Paliege A; Ketteler M; Mayer B; Tapp R; Bachmann S
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S104-15. PubMed ID: 9892150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison with other antihypertensive drugs, especially with ACEI].
    Hiwada K
    Nihon Rinsho; 1999 May; 57(5):1187-93. PubMed ID: 10361454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibiting angiotensin receptors in the brain: possible therapeutic implications.
    Unger T
    Curr Med Res Opin; 2003; 19(5):449-51. PubMed ID: 13678486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cardiologic and diabetologic aspects of therapy with angiotensin receptor blocking agents].
    Winkler G; Jermendy G; Matos L
    Orv Hetil; 2003 Sep; 144(38):1861-7. PubMed ID: 14596024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Scope].
    Kim S
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():644-7. PubMed ID: 15171449
    [No Abstract]   [Full Text] [Related]  

  • 29. Reducing cardiovascular morbidity and mortality in the elderly.
    Trenkwalder P
    Blood Press Suppl; 2000; 1():40-3. PubMed ID: 11059636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertension, diuretics, and uric acid.
    Reyes AJ; Leary WP
    Am J Hypertens; 2006 Oct; 19(10):1093-4. PubMed ID: 17027836
    [No Abstract]   [Full Text] [Related]  

  • 31. [Ameliorative effects on retinal disorder in diabetic SHRSP (stroke-prone spontaneously hypertensive rat)].
    Nagisa Y; Shintani A; Nakagawa S
    Nihon Rinsho; 2002 Oct; 60(10):1975-80. PubMed ID: 12397694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pre-treatment with candesartan protects from cerebral ischaemia.
    Ito T; Nishimura Y; Saavedra J
    J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):174-9. PubMed ID: 11881119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Angiotensin receptor antagonist for therapy of patients with hypertension].
    Rakugi H; Ogihara T
    Nihon Rinsho; 1997 Aug; 55(8):2075-80. PubMed ID: 9284426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The Diabetic Retinopathy Candesartan Trials (DIRECT) programme].
    Ohashi H; Takagi H
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():297-301. PubMed ID: 15999723
    [No Abstract]   [Full Text] [Related]  

  • 35. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
    Chung S; Park CW; Shin SJ; Lim JH; Chung HW; Youn DY; Kim HW; Kim BS; Lee JH; Kim GH; Chang YS
    Nephrol Dial Transplant; 2010 Feb; 25(2):389-99. PubMed ID: 19749146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin blockade prevents salt-induced injury of the renal circulation in spontaneously hypertensive rats.
    Susic D; Zhou X; Frohlich ED
    Am J Nephrol; 2009; 29(6):639-45. PubMed ID: 19155618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of long-term losartan and L-arginine treatment on haemodynamics, glomerular filtration, and SOD activity in spontaneously hypertensive rats.
    Miloradović Z; Jovović D; Mihailović-Stanojević N; Milanović JG; Milanović S
    Can J Physiol Pharmacol; 2008 Apr; 86(4):210-4. PubMed ID: 18418431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacotherapy for prehypertension--mission accomplished?
    Schunkert H
    N Engl J Med; 2006 Apr; 354(16):1742-4. PubMed ID: 16537661
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypertension, antihypertensive treatment and stroke prevention.
    Grassi G; Quarti F; Mancia G
    Neurol Sci; 2005 May; 26 Suppl 1():S22-3. PubMed ID: 15883684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin II receptor antagonist CV-11974 and cerebral blood flow autoregulation.
    Vraamark T; Waldemar G; Strandgaard S; Paulson OB
    J Hypertens; 1995 Jul; 13(7):755-61. PubMed ID: 7594439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.